Suppr超能文献

使用常温高钾血症对新生儿心脏进行心脏保护:分娩和终末心脏停搏的重要性。

Cardioprotection of neonatal heart using normothermic hyperkalaemia: the importance of delivery and terminal cardioplegia.

作者信息

Imura Hajime, Suleiman M-Saadeh

机构信息

Department of Surgery 2, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan.

出版信息

Mol Cell Biochem. 2008 Mar;310(1-2):1-9. doi: 10.1007/s11010-007-9660-x. Epub 2007 Nov 25.

Abstract

Cardioprotection of immature hearts remains controversial and largely based on the use of hypothermic cardioplegia. Recent clinical trials in pediatric open-heart surgery suggest that normothermic cardioplegic arrest is also cardioprotective. However, the advantages of using normothermic cardioplegia delivered as single- or multi-dose with or without terminal cardioplegia are unknown. This work investigates the efficacy of these techniques and the mechanism(s) underlying their protective effect. Neonatal (7-10 days) rabbit hearts in a working mode were exposed to normothermic global ischemia (60 or 90 min) protected with one of the following cardioplegic (hyperkalaemic buffer) protocols: single-dose, multi-dose infused every 30 min, single-dose or multi-dose with terminal cardioplegia. The extent of functional recovery (e.g., aortic and coronary flow), ischemic stress (e.g., myocardial ATP, lactate) and reperfusion injury (lactate dehydrogenase (LDH) release) were assessed. Recovery following 60 min global ischemia was improved (p < 0.05) by single-dose and multi-dose cardioplegic delivery (from 5% to 60% and 80%, respectively). Improved recovery was augmented by 2 min terminal cardioplegia (to 90% and 97% for single-dose and multi-dose, respectively). Extending ischemia to 90 min with single-dose resulted in 0% recovery that was not improved by 2 min terminal cardioplegia. However, 5 min (not 10 min) terminal cardioplegia significantly improved recovery (32%). Multi-dose followed by 5 min terminal cardioplegia resulted in full recovery. Cardioprotective interventions were associated with a reduction in LDH release and attenuated changes in myocardial metabolites. During normothermic cardioplegic arrest of neonatal heart: (i) multi-dose is superior to single-dose; (ii) terminal cardioplegia confers additional protection to single-dose and multi-dose; and (iii) protection is likely to be due to metabolic preservation.

摘要

未成熟心脏的心脏保护作用仍存在争议,且很大程度上基于低温心脏停搏的应用。近期小儿心脏直视手术的临床试验表明,常温心脏停搏同样具有心脏保护作用。然而,单剂量或多剂量使用常温心脏停搏液(无论是否使用终末心脏停搏液)的优势尚不清楚。本研究探讨了这些技术的疗效及其保护作用的潜在机制。将处于工作模式的新生(7 - 10日龄)兔心脏暴露于常温全心缺血(60或90分钟),并用以下心脏停搏液(高钾缓冲液)方案之一进行保护:单剂量、每30分钟输注一次的多剂量、单剂量或多剂量联合终末心脏停搏液。评估功能恢复程度(如主动脉和冠状动脉血流)、缺血应激(如心肌ATP、乳酸)和再灌注损伤(乳酸脱氢酶(LDH)释放)。单剂量和多剂量心脏停搏液给药可改善60分钟全心缺血后的恢复情况(p < 0.05)(分别从5%提高到60%和80%)。2分钟的终末心脏停搏可增强恢复效果(单剂量和多剂量分别提高到90%和97%)。单剂量将缺血时间延长至90分钟导致恢复率为0%,2分钟终末心脏停搏未改善此情况。然而,5分钟(而非10分钟)的终末心脏停搏显著改善了恢复情况(32%)。多剂量后接5分钟终末心脏停搏可实现完全恢复。心脏保护干预措施与LDH释放减少及心肌代谢物变化减弱相关。在新生心脏常温心脏停搏期间:(i)多剂量优于单剂量;(ii)终末心脏停搏液可为单剂量和多剂量提供额外保护;(iii)保护作用可能归因于代谢的维持。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验